Nearly 40% of dogs show signs of OA pain,1 but less than half are actually diagnosed2
Dogs with OA pain that are treated with NSAIDs receive ~60.5 days of therapy annually3
Support Your Clients at Every Step
OVERVIEW
Help Dog Owners Understand and Control Their Dog’s OA Pain
Osteoarthritis (OA) pain may be hard for dog owners to recognize. Use the resources on this page to educate your clients about OA and how it affects dogs, introduce them to Librela, and prepare them for follow-up appointments.
Did You Know
PRE-VISIT
Starting the Conversation
These resources can help educate your clients about the signs and symptoms of canine OA pain before their appointment, or they can help guide conversations with dog owners in your clinic.
In-Practice
Pet Owner Brochure
Help dog owners understand the signs of OA pain and treatment options available.
In-Practice
OA Checklist Poster
Print and hang up this poster about the signs of OA pain for dog owners to use right in your clinic.
Pre-Visit Email Attachment
Communicate with dog owners about OA pain before they come in for an appointment. Attach the provided PDF to an email or follow the customizable email instructions.
Social Media
Pre-Visit Social Post
Give dog owners an idea of what canine OA pain may look like. Post this image to your social channels or follow the customizable post instructions.
DIAGNOSIS
Why Librela?
Use these resources to guide conversations with dog owners about controlling canine OA pain with Librela and what to expect on their dog’s treatment journey.
In-Practice
Pet Owner Brochure
Help dog owners understand the signs of OA pain and treatment options available.
In-Practice or Email
OA Checklist
Print out for use in your clinic or email your clients a 1-pager about the signs and symptoms of OA pain.
Treatment with Librela Email Attachment
Send dog owners information about Librela and how it can control canine OA pain. Attach the provided PDF to an email or follow the customizable email instructions.
Social Media
Treatment with Librela Social Post
Show dog owners how Librela can help give their dogs with OA pain more days of play. Post this image to your social channels or follow the customizable post instructions.
In-Practice
Librela Talking Points
Use this 1-pager to answer questions about Librela, help dog owners understand how Librela controls canine OA pain, and what to expect during treatment.
ONGOING TREATMENT
Follow-up & Future Appointments
These resources can help you check in with your clients about their dog’s progress with Librela and make sure they’re making the most out of future appointments.
Follow-up Email
Send this email to your clients as a first check-in after initiating treatment with Librela and how they can prepare for follow-up appointments. Attach the provided PDF to an email or follow the customizable email instructions.
Thank You Email
After 2-3 weeks, send your clients this email as an additional check-in to assess progress. Attach the provided PDF to an email or follow the customizable email instructions.
Social Media
Follow-up Social Post
Remind dog owners to track their dog’s treatment progress and prepare for follow-up appointments. Post this image to your social channels or follow the customizable post instructions.
In-Practice
Back-to-Play Guide
This back-to-play treatment sheet can help your clients learn about the phased approach to returning their dog to play during their treatment journey with Librela.
Get a Canine OA Pain Checklist for your clients
View tips about examining dogs for OA
Find out more about the New Science of OA Pain
References:
- Wright A, Amodie DM, Cernicciaro N, et al. Identification of canine osteoarthritis using an owner-reported questionnaire and treatment monitoring using functional mobility tests. J Small Anim Pract. 2022;63(8):609-618. doi:10.1111/jsap.13500
- Librela Quant PMR: Pricing Sensitivity. Data on file. Zoetis Inc; May 2023.
- ZMR Kynetec PetTrak Data July 2022. Data on file. Zoetis Inc.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
© 2024 Zoetis Services LLC. All rights reserved. LIB-00011R3
IMPORTANT SAFETY INFORMATION:
See full Prescribing Information. For use in dogs only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Hypersensitivity reactions, including anaphylaxis, could potentially occur with self-injection. LIBRELA should not be used in breeding, pregnant or lactating dogs. LIBRELA should not be administered to dogs with known hypersensitivity to bedinvetmab. The most common adverse events reported in a clinical study were urinary tract infections, bacterial skin infections and dermatitis.